Krishna Institute of Medical Sciences Ltd Share Price

Healthcare

NSE: KIMS Small Cap ISIN: INE967H01025

As on 19 November 2025 at 01:28 IST

₹664.50

-11.55

(-1.71%)

Sell Buy

Krishna Institute of Medical Sciences Q1 FY26 Results:

Net profit declined 9% to ₹79 crores, compared to ₹87 crores in Q1 FY25. Total income in Q1 FY26 increased 27% to ₹879 crores from ₹693 crores in the same period last year.

About Krishna Institute of Medical Sciences Ltd

Krishna Institute of Medical Sciences Limited (KIMS) is a leading healthcare provider in India, specializing in multi-disciplinary medical services. KIMS falls under the healthcare sector, specifically within the sub-sector of hospital and healthcare services. Established in 2000, the company has many years of experience in providing high-quality medical care. The headquarters of Krishna Institute of Medical Sciences Limited is located in Hyderabad, Telangana. KIMS’s main products and services include a wide range of medical treatments and surgeries across various specialities. The hospitals are equipped with advanced medical technology to provide top-notch healthcare services. +

Over 1 Month

-6.09%

Over 6 Months

4.80%

Over 1 Year

21.21%

Over 3 Years

112.41%

Krishna Institute of Medical Sciences Ltd Summary

Close ₹676.05

Open ₹661.30

High ₹679.80

Low ₹660

Volume 2,95,767

Net Turnover (in Cr) ₹19.81

52Wk High ₹798.40

52Wk Low ₹474.05

52Wk High / Low

474.05

798.40

Krishna Institute of Medical Sciences Ltd Fundamentals

Key Financial Data

Market Cap (in Cr) ₹27,051.39

EPS (TTM) 7.10

Book Value (BV) 57.24

Div. Yield -

P/E (TTM) 92.75

Price/Book Value 11.83

Delivery % 49.76 %

Face Value 2

Key Ratios

PE Ratio 84.45

PB Ratio 11.80

EV to Sales 18.97

PEG Ratio -1.14

ROA 10.37

ROE 15.02

Debt-Equity 0.26

Net Profit Margin 21.88

Operating Profit Margin 35.29

Krishna Institute of Medical Sciences Ltd Financials

Consolidated

Standalone

Yearly

Quarterly

Profit and Loss

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Total Revenue	3,067	2,514.30	2,223.55	1,671.09	1,340.10
Total Expenses	2,519.70	2,054.50	1,753.47	1,223.74	1,061.09
Profit Before Tax	558.10	459.50	484.91	456.85	279.01
Profit After Tax	414.80	335.90	365.81	343.80	205.48
Operating Profit After Depreciation	637.60	506.80	500.62	463.38	311.51

Balance Sheet

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Fixed Assets	3,348.50	2,433.90	1,766.32	1,005.21	931.08
Total Non Current Assets	5,038.70	3,304.40	2,463.66	1,513.95	984.96
Total Current Assets	697.30	547.30	477.64	393.40	451.19
Total Assets	5,736	3,851.70	2,941.30	1,907.35	1,436.15
Total Shareholder's Fund	2,137.80	1,828.20	1,669.54	1,387.31	863.73

Cash Flow

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Net Cash From Operating Activities	581.80	521.09	432.09	324.03	355.97
Net Cash Used In Investing Activities	-1,115.80	-752.56	-415.75	-411.52	-354.18
Net Cash Used In Financing Activities	543.10	216.76	19.64	61	9.82

Profit and Loss

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Total Revenue	1,440.80	1,240.30	1,156.31	1,167.55	942.30
Total Expenses	1,048.50	922.10	818.97	796.55	688.04
Profit Before Tax	403.10	318.20	337.33	371	254.26
Profit After Tax	302.90	235.30	252.49	278.37	188.65
Operating Profit After Depreciation	415.50	321.80	338.49	375.47	269.05

Balance Sheet

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Fixed Assets	773.30	673.90	612.28	591.97	582.39
Total Non Current Assets	2,889.70	2,095.40	1,575.02	1,237.50	846.50
Total Current Assets	299.40	301.20	237.04	331.28	367.23
Total Assets	3,189.10	2,396.60	1,812.07	1,568.78	1,213.73
Total Shareholder's Fund	2,168	1,866.40	1,630.86	1,377.55	907.32

Cash Flow

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Net Cash From Operating Activities	293.60	262.40	271.05	284.37	291.35
Net Cash Used In Investing Activities	-626.60	-568.60	-237.67	-375.08	-316.60
Net Cash Used In Financing Activities	338.60	288.60	-15.14	75.98	25.37

Particulars (in ₹ Cr.)	2025-09	2025-06	2025-03	2024-12	2024-09
Total Revenue	960.70	871.60	796.90	772.40	777.30
Total Expenses	756.70	679	598.90	585.20	559.20
Profit Before Tax	96.80	113.70	134	134.60	162.20
Profit After Tax	72	85	106.10	92.50	120.70
Operating Profit after Depreciation	208.20	199.70	202.50	205	223.10

Particulars (in ₹ Cr.)	2025-09	2025-06	2025-03	2024-12	2024-09
Total Revenue	430	373.40	345.90	347.50	363.30
Total Expenses	317.80	275.90	237.20	244.60	252.20
Profit Before Tax	86.10	79.70	120.50	101.90	99.10
Profit After Tax	63.50	58.80	93.50	76.50	72.20
Operating Profit after Depreciation	124.70	109.70	132.90	123.50	117.70

Krishna Institute of Medical Sciences Ltd Technicals

Support and Resistance

S3 S2 S1 Pivot R1 R2 R3

S1 664.10

S2 652.15

S3 644.30

Pivot 671.95

R1 683.90

R2 691.75

R3 703.70

Moving Average

20 SMA 710.06

50 SMA 720.80

100 SMA 724.15

200 SMA 671.50

Krishna Institute of Medical Sciences Ltd Corporate Actions

No available data

AGM Date: 11 Aug 2022

Outcome of Board Meeting held on 19th May 2022 pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 The 20th Annual General Meeting of the Company was held on August 11, 2022, and the business mentioned in the Notice dated May 19, 2022, was transacted. In this regard, please find enclosed the proceedings as required under Regulation 30, Part A of Schedule - III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. In continuation to our intimation dated July 18, 2022, the 20th AGM of the Company was held on August 11, 2022, in this regard, please find enclosed the following a) voting results Pursuant to Regulation 44 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, enclosed as Annexure 1 and b) The Report of Scrutinizer on remote e-voting and voting at AGM (by electronic means) is enclosed as Annexure- II. Krishna Institute of Medical Sciences Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015 (As per BSE Announcement Dated on 12/08/2022)

AGM Date: 30 Aug 2023

AGM 30/08/2023 The 21st Annual General Meeting of the Company will be held on Wednesday, 30th August 2023. (As Per BSE Announcement dated on 18.05.2023) 21st AGM of the Company (As Per BSE Announcement dated on 05.08.2023) Proceedings of the 21st Annual General Meeting of the Company (As Per BSE Announcement dated on 30.08.2023) Voting results and scrutinizer''s report of the 21st Annual General Meeting (As Per BSE Announcement Dated on 01/09/2023)

AGM Date: 29 Aug 2024

Annual General Meeting (AGM): The 22nd Annual General Meeting of the Company will be held on Thursday, 29th August 2024. Approved the revised notice of the 22nd Annual General Meeting of the Company (As Per BSE Announcement Dated on: 28/06/2024) 22nd Annual General Meeting of the Company to be held on 29th August, 2024 at 4:00 PM (As Per BSE Announcement dated on 06.08.2024) Proceedings of the 22nd AGM (As per BSE Announcement Dated on 29/08/2024) Results of AGM (As per BSE Announcement Dated on 02/09/2024)

AGM Date: 29 Aug 2025

The 23rd Annual General Meeting of the Company will be held on Friday, 29th August 2025. Notice convening 23rd Annual General Meeting to be held on Friday, 29th August, 2025. (As Per BSE Announcement Dated on: 07/08/2025) Addendum to the 23rd Annual General Meeting Notice (As Per BSE Announcement Dated on: 21/08/2025) Outcome of 23rd Annual General meeting of Krishna Institute of Medical Sciences Limited (As Per BSE Announcement Dated on:29.08.2025) Voting Results and Scrutinizer Report for the 23rd Annual General Meeting (As Per BSE Announcement Dated on:01.09.2025)

Krishna Institute of Medical Sciences Ltd Peer Comparison

Company	Price	Market Cap (in Cr)
Max Healthcare Institute Ltd	₹1,121.90	₹1,09,099.45
Apollo Hospitals Enterprise Ltd	₹7,488.40	₹1,07,671.70
Fortis Healthcare Ltd	₹944.15	₹71,279.37
Narayana Hrudayalaya Ltd	₹2,027.90	₹41,442.33
Aster DM Healthcare Ltd	₹678.35	₹35,146.74

Krishna Institute of Medical Sciences Ltd Top Mutal Funds Invested

Fund Name	AUM
Invesco India Smallcap Fund	5.08%
Kotak Small Cap Fund	3.38%
AXIS Flexi Cap Fund	3.37%
AXIS Small Cap Fund	2.84%
SBI Small Cap Fund	2.41%

Krishna Institute of Medical Sciences Ltd News

Krishna Institute of Medical Sci. to table results

On 7 November 2025

25 Oct 2025, 11:23 am

KIMS commences operations of new hospital at Mahadevapura, Bengaluru

15 Sep 2025, 06:20 pm

Krishna Institute of Medical Sci. to announce Quarterly Result

On 6 August 2025

25 Jul 2025, 09:50 am

Krishna Institute of Medical Sci. AGM scheduled

On 29 August 2025

13 May 2025, 04:55 pm

Krishna Institute of Medical Sci. to convene board meeting

On 12 May 2025

02 May 2025, 04:10 pm

Krishna Institute of Medical Sciences Ltd Stock Analysis

Annual revenue for Krishna Institute of Medical Sciences Ltd increased by 16.17% to ₹1,440.80 crore in FY 2025 from ₹1,240.30 crore in FY 2024.
Annual Net Profit for Krishna Institute of Medical Sciences Ltd increased by 28.73% to ₹302.90 crore in FY 2025 from ₹235.30 crore in FY 2024.
Promoter Shareholding in Krishna Institute of Medical Sciences Ltd remains unchanged by 0.00% in the most recent quarter, from 34.11% in June 2025 to 34.11% in September 2025.
Krishna Institute of Medical Sciences Ltd delivered a 1-year return of 21.21% compared to the Nifty 50, which provided a return of 10.91% as of the last trading session.
Krishna Institute of Medical Sciences Ltd share price moved down by 1.71% from its previous close of INR ₹676.05. The latest Krishna Institute of Medical Sciences Ltd share price is INR ₹664.50.
Krishna Institute of Medical Sciences Ltd share price today has been at a low of 663 and a high of 682.65. Over the past 52 weeks, the Krishna Institute of Medical Sciences Ltd share price has seen a low of 474.05 and a high of 798.40.

About Krishna Institute of Medical Sciences Ltd

Krishna Institute of Medical Sciences Limited (KIMS) is a leading healthcare provider in India. It specializes in multi-disciplinary medical services. The company operates a network of hospitals that offer comprehensive healthcare services. These include critical care, endoscopic surgeries, and more.
KIMS falls under the healthcare sector. It specifically operates within the sub-sector of hospital and healthcare services. Established in 2000, the company has years of experience in providing high-quality medical care.
The headquarters of Krishna Institute of Medical Sciences Limited is located in Hyderabad. It is in the state of Telangana, India. Dr. Bhaskar Rao Bollineni founded the company. The promoters of the company include Bhaskara Rao Bollineni, with a 26.27% stake. It also has a team of professional managerial promoters who manage the operations of the company. They are-

Abhinay Bollineni
Anitha Dandamudi
Adwik Bollineni
Saumen Chakraborty

KIMS’s main services include a wide range of medical treatments and surgeries across various specialities. The hospitals are equipped with state-of-the-art facilities and advanced medical technology. This ensures the provision of top-notch healthcare services. The company also focuses on medical research and education. This contributes to the advancement of medical science.
While KIMS is a significant player in the healthcare sector, it is not the largest in terms of market share or capitalization. However, it holds a strong position and is highly respected for its contributions to the industry. The company’s stock is not the number one in the sector, but it is considered a strong performer with consistent financial growth.
The registered office of KIMS is in Secunderabad, Telangana and the office of the registrars is in Coimbatore, Tamil Nadu. Krishna Institute of Medical Sciences Limited is a key player in the Indian healthcare sector. It is known for its extensive range of medical services and commitment to quality. With strong promoter shareholding and a dedicated management team, KIMS continues to play a vital role.

The Vision of Krishna Institute of Medical Sciences Limited

Krishna Institute of Medical Sciences Limited (KIMS) envisions a future where it stands as a beacon of excellence in healthcare. The company’s vision is rooted in its commitment to providing high-quality healthcare services. KIMS aims to be a leader in patient care and community health.
Central to KIMS’s vision is the goal of delivering exceptional patient care. The company strives to create a patient-centric environment. In this setting, the needs and well-being of patients are the top priority. This involves providing advanced medical treatments. It also ensures that patients receive compassionate and personalized care.
Innovation in medical technology and practices is another cornerstone of KIMS’s vision. The company invests heavily in research and development to stay at the forefront of medical advancements. This focus on innovation allows KIMS to offer cutting-edge treatments and procedures that improve patient outcomes. The vision includes adopting the latest medical technologies. It also focuses on continuously improving healthcare delivery methods.
KIMS also emphasizes the importance of accessibility in its vision. The company aims to make high-quality healthcare services available to a broader population. This involves expanding its network of hospitals and healthcare facilities to reach underserved areas. KIMS is committed to reducing the barriers to healthcare access, ensuring that more people can benefit from its services.
Education and training are integral to KIMS’s vision. The company recognizes the importance of developing skilled healthcare professionals. These professionals are crucial for delivering top-notch medical care. KIMS invests in medical education and training programs. These initiatives help nurture the next generation of doctors and healthcare workers. This focus on education ensures that KIMS has a talented and knowledgeable workforce ready to meet future healthcare challenges.
Sustainability is a key aspect of KIMS’s vision. The company is dedicated to implementing eco-friendly practices in its operations. This includes reducing waste and using sustainable materials. KIMS believes that healthcare providers have a responsibility to protect the environment and promote sustainable practices. The vision includes a commitment to minimizing the environmental impact of its activities.
Community engagement is another important element of KIMS’s vision. The company aims to play an active role in improving public health and well-being. This involves participating in community health programs and providing free medical services to those in need. KIMS believes that a healthy community is the foundation of a prosperous society. The company is committed to contributing to community health initiatives.
KIMS’s vision also includes a strong focus on ethical practices. The company is committed to maintaining the highest standards of integrity and transparency in all its operations. This involves adhering to ethical guidelines and promoting fair practices. KIMS believes that trust is essential in healthcare. The company strives to build and maintain trust with its patients and stakeholders.
The vision of KIMS is not just about providing healthcare services; it is about transforming the healthcare landscape. The company aims to set new standards in medical care and community health. KIMS envisions a future where it is recognized as a leader in healthcare, known for its excellence and commitment to improving lives.